drugset
drugset / Trial / NCT00841230

Deanxit and Rivotril in Tinnitus Patients

NCT00841230 ↗

Phase 4 Completed 50 enrolled University Hospital, Antwerp
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to investigate whether increased tinnitus reduction can be obtained with Deanxit in patients already receiving Rivotril.

Timeline

Start
2009-02
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Deanxit Unknown — —

Indications

tinnitus